Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Methotrexate 2.5 mg Tablets

Active Ingredient:
methotrexate
Company:  
Cipla EU Ltd See contact details
ATC code: 
L04AX03
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Educational Materials for Healthcare Professionals - Methotrexate

{healthcare_pro_orange} For Healthcare Professionals
To minimise the risk of overdose from patients incorrectly taking methotrexate daily instead of once weekly for autoimmune diseases
{pdf_link}

Patient Alert Card - Methotrexate

{healthcare_pro_orange} For Healthcare Professionals
The Patient Card contains important safety information the patient needs to be aware of when receiving treatment with methotrexate for conditions including arthritis and psoriasis.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Cipla EU Ltd
Company image
Address
Dixcart House, Addlestone Road, Bourne Business Park, Addlestone,, KT15 2LE, UK
WWW
http://www.cipla.com
Telephone
+44 (0)1932 264688
Medical Information Direct Line
0800 0472144
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)207 399 4883
Stock Availability
[email protected]